Product Description
Teneligliptin And Metformin Hydrochloride Sustained-Release Tablets IP are a combination of two medications that are used to treat type 2 diabetes. Teneligliptin is a DPP-4 inhibitor that helps to lower blood sugar levels by increasing the levels of incretin hormones in the body. Metformin is a biguanide that helps to lower blood sugar levels by decreasing the amount of glucose produced by the liver and improving the bodys sensitivity to insulin. These tablets are formulated to release the medication slowly over time, providing consistent blood sugar control throughout the day.
FAQs of Teneligliptin And Metformin Hydrochloride Sustained-Releasr Tablets IP:
Q: What is the recommended dosage for Teneligliptin And Metformin Hydrochloride Sustained-Release Tablets IP?
A: The recommended dosage for these tablets is 20 mg per day, taken orally with meals.
Q: What is the storage requirement for these tablets?
A: These tablets should be stored in a dry place at room temperature.
Q: Are there any side effects associated with these tablets?
A: Some common side effects of these tablets include nausea, vomiting, diarrhea, headache, and dizziness. If you experience any severe side effects, please consult your doctor immediately.
Q: What is the origin of these tablets?
A: These tablets are manufactured in India.
Q: What is the form of these tablets?
A: These tablets are in a physical form of sustained-release tablets in a dosage form of tablets and are classified as general medicines. Note: This product description and FAQ are based on the given product name and specifications. No company or brand name is added to the content.